Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Antengene HK$2.79 billion IPO

Davis Polk advised Antengene Corporation Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…

Auna $300 million high-yield notes offering

Davis Polk advised Auna S.A.A. in connection with its Rule 144A/Regulation S offering of $300 million aggregate principal amount of its 6.500% senior notes due 2025. The notes are…

Burger King Brasil R$510 million equity offering

Davis Polk advised the joint bookrunners on the equity offering of common shares of BK Brasil Operação e Assessoria a Restaurantes S.A. for an aggregate amount of approximately R$510…

Kodiak Sciences $645 million follow-on offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $645.0 million public offering of 5,972,222 shares of common stock by…

Plug Power $845.5 million stock offering

Davis Polk advised the representative of the several underwriters in connection with the SEC-registered offering of 38,000,000 shares of common stock of Plug Power Inc. for $845.5…

Population Health Investment $172.5 million IPO

Davis Polk advised the sole book-running manager in connection with the $172.5 million initial public offering of 17,250,000 units of Population Health Investment Co., Inc., which includes…

China Biologic going-private transaction

Davis Polk is advising the special committee of the board of directors of China Biologic Products Holdings, Inc. (“China Biologic”) in connection with the going-private acquisition of China…
Back to top